Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
4D Molecular Therapeutics Inc
About FDMT
4D Molecular Therapeutics, Inc. is a late-stage biotechnology company advancing durable and disease-targeted therapeutics. The Company's lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) with a single, safe, intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. Its lead indication for 4D-150 is wet age-related macular degeneration, which is in Phase III development, and second indication is diabetic macular edema. The Company is developing 4D-710 for the treatment of a range of people with cystic fibrosis independent of their specific CFTR mutation. 4D-710 is an investigational genetic medicine candidate using the A101 vector for the treatment of cystic fibrosis lung disease. The Company's non-core programs include 4D-175, 4D-725, and 4D-310.
Find out what a historical investment in 4D Molecular Therapeutics Inc would be worth today using our FDMT stock calculator.
Market Capitalisation
$439.38M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
523.45K
High today
$8.79
Low today
$8.37
Open price
$8.52
52-week high
$12.34
52-week low
$3.37
Ready to start your investing journey with Stake?
Open an accountHow do I buy FDMT shares in Australia?
Buying FDMT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in 4D Molecular Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FDMT
What is the ticker symbol of 4D Molecular Therapeutics Inc?
The ticker symbol for 4D Molecular Therapeutics Inc is FDMT.
How much is one share of FDMT?
One share of FDMT is valued at $8.52 as of 20 May 2026.
What is the market capitalisation of 4D Molecular Therapeutics Inc FDMT?
As of 20 May 2026 4D Molecular Therapeutics Inc has a market cap of $439.38M.
What is the 52-week high for 4D Molecular Therapeutics Inc stock?
The 4D Molecular Therapeutics Inc 52-week high stock price is $12.34.
What is the 52-week low for 4D Molecular Therapeutics Inc stock?
The 4D Molecular Therapeutics Inc 52-week low stock price is $3.37.
Can I buy FDMT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FDMT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FDMT on Stake
- Buy FDMT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FDMT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FDMT related stocks